BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6458525)

  • 21. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the antibacterial activity of the combination cefazolin-dicloxacillin].
    Ripa S; Tarsi R; Orpianesi C; Prenna M
    Nuovi Ann Ig Microbiol; 1976; 27(3):265-76. PubMed ID: 1026925
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-lactamase resistance of cephazolin and other cephalosporins.
    Goodwin CS; Hill JP
    Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative sensitivity of penicillinase producing Staphylococcus aureus to four cephalosporin antibiotics.
    Bremner DA; Fortune J
    N Z Med J; 1975 Sep; 82(548):189-90. PubMed ID: 1059959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulating properties of newer cephalosporins: a preliminary classification.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):219-21. PubMed ID: 3334561
    [No Abstract]   [Full Text] [Related]  

  • 30. Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.
    Yourassowsky E; van der Linden MP; Crokaert F
    Antimicrob Agents Chemother; 1990 Apr; 34(4):505-9. PubMed ID: 2344158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of inoculum growth phase when using an in vitro pharmacokinetic model to evaluate beta-lactam antibiotics.
    Xerri L; Broggio R; Caro B; Scheda P
    Chemioterapia; 1988 Apr; 7(2):79-85. PubMed ID: 3293819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of 7 cephalosporins on "Staphylococcus aureus" by the method of population analysis (author's transl)].
    Sirot D; Sirot J; Cluzel R; Joly B
    Pathol Biol (Paris); 1977 Nov; 25(9):605-10. PubMed ID: 341049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
    Uri JV
    Acta Microbiol Hung; 1987; 34(1):39-44. PubMed ID: 3630630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin.
    Actor P; Uri JV; Phillips L; Sachs CS; Guarini JR; Zajac I; Berges DA; Dunn GL; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Aug; 28(8):594-601. PubMed ID: 808525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cefuroxime, a new antibiotic. Action in vitro and in vivo].
    Orsolini P; Xerri L
    G Ital Chemioter; 1977; 24(1-2):49-55. PubMed ID: 615762
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibacterial activity of a carbenicillin-cephaloridin combination].
    Ripa S; Prenna M
    Ann Sclavo; 1975 SEP-OCT; 17(5):749-65. PubMed ID: 821404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinical studies on cefuroxime in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Dec; 32(12):1219-29. PubMed ID: 393846
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of 7 beta-[1-(2-aminothiazol-4-yl)-1-cyclopropanecarboxyamido]cephem derivatives.
    Nishimura S; Yasuda N; Sasaki H; Sakane K; Takaya T
    J Antibiot (Tokyo); 1990 Oct; 43(10):1278-85. PubMed ID: 2124209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.